Investing.com - IDEXX Labs reported second quarter earnings that beat analysts' expectations on Thursday and revenue that fell short of forecasts.
The firm reported earnings per share of $1.43 on revenue of $620.1M. Analysts polled by Investing.com anticipated EPS of $1.36 on revenue of $627.27M. That compared to EPS of $1.23 on revenue of $580.75M in the same period a year earlier. The company had reported EPS of $1.17 on revenue of $576.06M in the previous quarter.
IDEXX Labs follows other major Healthcare sector earnings this month
On July 16, J&J reported second quarter EPS of $2.58 on revenue of $20.56B, compared to forecasts of EPS of $2.46 on revenue of $20.29B.
Pfizer earnings beat analysts' expectations on Monday, with second quarter EPS of $0.8 on revenue of $13.26B. Investing.com analysts expected EPS of $0.75 on revenue of $13.41B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar